Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yen-Jung Chiu

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Heliyon|May 14, 2024
Automated medication verification system (AMVS): System based on edge detection and CNN classification drug on embedded systemsYen-Jung Chiu
Plos One|January 9, 2026
LIMPACAT: Multi-omics attention transformer for immune prediction in liver cancer using whole-slide imagingYen-Jung Chiu
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|December 3, 2025
Bridging VAE-Derived Latent Gene Representations and Graph Neural Networks for Improved Drug Response PredictionYen-Hua Huang, Yen-Jung Chiu
Cancer Medicine|June 27, 2023
Deconvolution of bulk gene expression profiles reveals the association between immune cell polarization and the prognosis of hepatocellular carcinoma patientsYen-Jung Chiu, Chung-En Ni, Yen-Hua Huang
BMC Medical Genomics|December 21, 2019
Improved cell composition deconvolution method of bulk gene expression profiles to quantify subsets of immune cellsYen-Jung Chiu, Yi-Hsuan Hsieh, Yen-Hua Huang
BMC Medical Genomics|November 1, 2023
HArmonized single-cell RNA-seq Cell type Assisted Deconvolution (HASCAD)Yen-Jung Chiu, Chung-En Ni, Yen-Hua Huang
Computational Biology and Chemistry|June 16, 2023
TSSUNet-MB - ab initio identification of σ<sup>70</sup> promoter transcription start sites in Escherichia coli using deep multitask learningChung-En Ni, Duy-Phuong Doan, Yen-Jung Chiu, et al.
Oncotarget|May 7, 2016
Nesfatin-1/Nucleobindin-2 enhances cell migration, invasion, and epithelial-mesenchymal transition via LKB1/AMPK/TORC1/ZEB1 pathways in colon cancerJung-Yu Kan, Meng-Chi Yen, Jaw-Yuan Wang, et al.
Journal of Cellular Physiology|December 30, 2014
Chemokine (C-C Motif) Ligand 5 is Involved in Tumor-Associated Dendritic Cell-Mediated Colon Cancer Progression Through Non-Coding RNA MALAT-1Jung-Yu Kan, Deng-Chyang Wu, Fang-Jung Yu, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Heliyon|May 14, 2024
Automated medication verification system (AMVS): System based on edge detection and CNN classification drug on embedded systemsYen-Jung Chiu
Plos One|January 9, 2026
LIMPACAT: Multi-omics attention transformer for immune prediction in liver cancer using whole-slide imagingYen-Jung Chiu
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|December 3, 2025
Bridging VAE-Derived Latent Gene Representations and Graph Neural Networks for Improved Drug Response PredictionYen-Hua Huang, Yen-Jung Chiu
Cancer Medicine|June 27, 2023
Deconvolution of bulk gene expression profiles reveals the association between immune cell polarization and the prognosis of hepatocellular carcinoma patientsYen-Jung Chiu, Chung-En Ni, Yen-Hua Huang
BMC Medical Genomics|December 21, 2019
Improved cell composition deconvolution method of bulk gene expression profiles to quantify subsets of immune cellsYen-Jung Chiu, Yi-Hsuan Hsieh, Yen-Hua Huang
BMC Medical Genomics|November 1, 2023
HArmonized single-cell RNA-seq Cell type Assisted Deconvolution (HASCAD)Yen-Jung Chiu, Chung-En Ni, Yen-Hua Huang
Computational Biology and Chemistry|June 16, 2023
TSSUNet-MB - ab initio identification of σ<sup>70</sup> promoter transcription start sites in Escherichia coli using deep multitask learningChung-En Ni, Duy-Phuong Doan, Yen-Jung Chiu, et al.
Oncotarget|May 7, 2016
Nesfatin-1/Nucleobindin-2 enhances cell migration, invasion, and epithelial-mesenchymal transition via LKB1/AMPK/TORC1/ZEB1 pathways in colon cancerJung-Yu Kan, Meng-Chi Yen, Jaw-Yuan Wang, et al.
Journal of Cellular Physiology|December 30, 2014
Chemokine (C-C Motif) Ligand 5 is Involved in Tumor-Associated Dendritic Cell-Mediated Colon Cancer Progression Through Non-Coding RNA MALAT-1Jung-Yu Kan, Deng-Chyang Wu, Fang-Jung Yu, et al.
Pageof 1